High doses of cyclophosphamide in the treatment of severe systemic lupus erythematosus.
Glisic
B
B
Clinic of Rheumatology and Clinical Immunology, Military Medical Academy, Belgrade, Yugoslavia.
Popovic
M
M
Popovic
R
R
Mitrovic
D
D
Stefanovic
D
D
Dimitrijevic
M
M
D003520:Cyclophosphamide / Q000627:therapeutic use*; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000503:physiopathology; D008181:Lupus Nephritis / Q000188:drug therapy*; D020945:Lupus Vasculitis, Central Nervous System / Q000188:drug therapy*; D008297:Male; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide